Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492944 · ClinicalTrials.gov registry record
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason
A clinical trial of Crohn Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03492944 is a study of Crohn Disease that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 25 participants, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03492944, a study of Crohn Disease, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators plan to compare contrast-enhanced ultrasound to CT and MRI for the detection and quantification of intestinal inflammation in the the setting of pediatric small bowel Crohns disease
Conditions Studied
Interventions
- DEVICE Ultrasound Imaging
- DRUG Ultrasound Microbubble Contrast Agent
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-03-06 |
| Est. Completion | 2026-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03492944
The ClinicalTrials.gov registry entry for NCT03492944 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (88% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 2 interventions - of which Ultrasound Imaging is the first listed.
NCT03492944 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03492944 about?
NCT03492944 is a clinical study titled "Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason". The investigators plan to compare contrast-enhanced ultrasound to CT and MRI for the detection and quantification of intestinal inflammation in the the setting of pediatric small bowel Crohns disease
What is the current status of trial NCT03492944?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2020-03-06. Estimated completion is 2026-02.
What conditions does trial NCT03492944 study?
This clinical trial studies the following conditions: Crohn Disease.
What interventions are being tested in trial NCT03492944?
The interventions under investigation include: Ultrasound Imaging (DEVICE), Ultrasound Microbubble Contrast Agent (DRUG).
Who is sponsoring clinical trial NCT03492944?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03492944 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
Low Dose IL-2 for the Treatment of Crohn's Disease
RECRUITING · Phase 1
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.